ANGELA BONHAM: Open Payments
NPI 1689273773 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 51 payments from 16 companies in 2025. Trend: 2023 $1,645 · 2024 $959 · 2025 $1,065
Food & beverage: $965Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $203 |
| GlaxoSmithKline, LLC. | 16 | $152 |
| HARMONY BIOSCIENCES LLC | 1 | $100 |
| GENZYME CORPORATION | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Grifols USA, LLC | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Electromed, Inc. | 7 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $40 |
Products named: DUPIXENT, FASENRA, TRELEGY ELLIPTA, Prolastin-C Liquid, GLASSIA, AIRSUPRA, JASCAYD, NUCALA.
Industry payments across IN — which companies pay providers there.
